Abstract
Tylosis with esophageal cancer (TOC) is a rare familial cancer syndrome inherited in an autosomal-dominant manner and characterized by esophageal cancer susceptibility and hyperkeratotic skin lesions. Two heterozygous missense mutations in the RHBDF2 gene were recently reported to be associated with TOC in three families: a p.Ile186Thr mutation was found in families from the UK and the US and a p.Pro189Leu mutation was detected in a German TOC family. We aimed to validate these novel results in an independent material by screening RHBDF2 in a previously unreported Finnish TOC family. We identified a new missense mutation, p.Asp188Asn, segregating with TOC in the Finnish family, and interestingly the detected mutation alters a codon located between the two previously reported mutation sites. Thus, we confirmed RHBDF2 mutations as the underlying cause of the TOC syndrome and our results suggest that the TOC associated mutations might be specific for this particular site in the RHBDF2 gene. These results enable the genetic counseling and diagnostic mutation screening of the members of TOC families.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Ellis A, Field JK, Field EA et al (1994) Tylosis associated with carcinoma of the oesophagus and oral leukoplakia in a large Liverpool family–a review of six generations. Eur J Cancer B Oral Oncol 30B:102–112
Hennies HC, Hagedorn M, Reis A (1995) Palmoplantar keratoderma in association with carcinoma of the esophagus maps to chromosome 17q distal to the keratin gene cluster. Genomics 29:537–540
Stevens HP, Kelsell DP, Bryant SP et al (1996) Linkage of an American pedigree with palmoplantar keratoderma and malignancy (palmoplantar ectodermal dysplasia type III) to 17q24. Literature survey and proposed updated classification of the keratodermas. Arch Dermatol 132:640–651
Varela AB, Blanco Rodriguez MM, Boullosa PE, Silva JG (2011) Tylosis a with squamous cell carcinoma of the oesophagus in a Spanish family. Eur J Gastroenterol Hepatol 23:286–288
Risk JM, Field EA, Field JK et al (1994) Tylosis oesophageal cancer mapped. Nat Genet 8:319–321
Risk JM, Evans KE, Jones J et al (2002) Characterization of a 500 kb region on 17q25 and the exclusion of candidate genes as the familial Tylosis Oesophageal Cancer (TOC) locus. Oncogene 21:6395–6402
Langan JE, Cole CG, Huckle EJ et al (2004) Novel microsatellite markers and single nucleotide polymorphisms refine the tylosis with oesophageal cancer (TOC) minimal region on 17q25 to 42.5 kb: sequencing does not identify the causative gene. Hum Genet 114:534–540
Iwaya T, Maesawa C, Ogasawara S, Tamura G (1998) Tylosis esophageal cancer locus on chromosome 17q25.1 is commonly deleted in sporadic human esophageal cancer. Gastroenterology 114:1206–1210
von Brevern M, Hollstein MC, Risk JM et al (1998) Loss of heterozygosity in sporadic oesophageal tumors in the tylosis oesophageal cancer (TOC) gene region of chromosome 17q. Oncogene 17:2101–2105
Blaydon DC, Etheridge SL, Risk JM et al (2012) RHBDF2 mutations are associated with tylosis, a familial esophageal cancer syndrome. Am J Hum Genet 90:340–346
Adrain C, Zettl M, Christova Y, Taylor N, Freeman M (2012) Tumor necrosis factor signaling requires iRhom2 to promote trafficking and activation of TACE. Science 335:225–228
Zettl M, Adrain C, Strisovsky K, Lastun V, Freeman M (2011) Rhomboid family pseudoproteases use the ER quality control machinery to regulate intercellular signaling. Cell 145:79–91
Acknowledgments
The authors would like to thank Mairi Kuris and Sini Nieminen for technical assistance. The study was supported by grants from the Academy of Finland (Center of Excellence in Translational Genome-Scale Biology and Grant 212901).
Conflict of interests
The authors declare no conflicts of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Saarinen, S., Vahteristo, P., Lehtonen, R. et al. Analysis of a Finnish family confirms RHBDF2 mutations as the underlying factor in tylosis with esophageal cancer. Familial Cancer 11, 525–528 (2012). https://doi.org/10.1007/s10689-012-9532-8
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10689-012-9532-8